Trouble Continues For Telecoms

We last talked about Telecom stocks about six months ago, when their stocks came under significant pressure due to slowing growth, competition concerns, and regulatory issues. We then discussed them in October when investors dumped defensive stocks for higher-yielding treasuries with no risk.

Prices have since rebounded sharply with the broader market as investors priced in Fed rate cuts this year. However, Verizon was back in the news today for a not-so-great reason. Let’s dig in. 👇

The telecom giant reminded investors that selling landlines and internet connections to businesses is much tougher today than a few decades ago. As a result, it’s writing down the value of its business division that offers services to a wide range of companies. The $5.8 billion charge will impact its fourth-quarter results, which is why it’s warning investors ahead of time. ⚠️

Executives said a strategic review caused it to reduce its financial projections and revise the unit’s overall value, given that revenues fell 2.9% YoY through the first nine months of 2023. Competition from smaller rivals and the unbundling of phone and broadband products remain structural headwinds for the business

Luckily, Verizon still generates most of its profit from cellphone services as the largest U.S. wireless company by subscriber numbers. With that said, that segment is not without challenges. Competition from AT&T and T-Mobile has caused customer losses and slowed revenue growth, with fears that Dish Network could join the fray following its merger with Echostar. 📱

Overall, investors are on high alert ahead of these companies’ earnings reports. They’ll be watching closely to see how management discusses plans to drive revenue growth, as well as for potential risks they disclose, like the Environmental Protection Agency’s (EPA) probe into lead telecom cables. 📝

As for the stocks, it’s been a lackluster decade for $VZ and $T shares, while $TMUS (not shown) has risen over 400%. We’ll have to wait and see if they can turn things around this year. 📊

Learn More About...

Biotech Buyout Spree Continues

It may be the last week of the year, but many companies are rushing to get deals done before year-end. Two significant transactions in the biotech space were announced today, so let’s dive in. 👇

The first deal involves RayzeBio, which raised $358 million via an initial public offering (IPO) just three months ago. However, its time as a public company is being cut short by Bristol Myers Squibb, which is acquiring the radiopharmaceutical therapeutics company for $62.50 per share in cash. 💰

Read It

Japan’s Nippon Takes Over U.S. Steel

After months of bidding, U.S. Steel finally has a buyer. However, the auction’s winner has some parties concerned. 🤔

Japan’s Nippon Steel emerged as the top bidder for the 122-year-old steelmaker, beating out offers from Cleveland-Cliffs, ArcelorMittal, and Nucor. Its $55 per share price represents a 142% premium to where $X shares were trading before Cleveland-Cliffs’ $35-per-share offer kicked off the bidding war.

Read It

JetBlue Jumps As Icahn Accumulates

It’s been a rough few months for JetBlue shareholders after the airline’s merger with Spirit Airlines was blocked by U.S. regulators. However, the stock is popping after hours on news that a billionaire hedge fund manager is dumpster diving and sees value in the stock. 💸

Activist investor Carl Icahn reported a nearly 10% stake, which he’s accumulated on the belief that the stock is undervalued following its recent selloff. He’s already had discussions with the company regarding possibly attaining board representation.

Read It

A Chip Off The Holiday News Flow

It’s a slow week in the market, but as usual, there’s some news out of the semiconductor space. Let’s take a look. 👀

First up is Israel granting Intel $3.2 billion to support the company’s biggest investment in the country. Intel will not only build a $25 billion factory that creates thousands of jobs but will also buy $16.6 billion in goods and services from Israeli suppliers over the next decade. It is anticipated that the plant will open in 2028 and operate through at least 2035. 🏭

Read It